Work

Targeted mitochondrial transfer by enucleated MSC-derived microvesicles restores foam macrophage homeostasis to attenuate atherosclerotic progression

Year: 2026
Type: article
Abstract: Mitochondrial dysfunction is a fundamental driver of the onset and progression of atherosclerosis, as it disrupts cell metabolic homeostasis and fuels lipid accumulation and chronic inflammatory activation. However, therapeutic strategies that effectively restore mitochondrial function remain limited, and mitochondria delivery system capable of selectively targeting atherosclerotic plaques are still lacking. Here, we engineered a mitochondria-loaded vesicular system with inflamed endothelium-targeting capability (Mito@euMVs-Vt) to re-establish mitochondrial homeostasis in foam macrophages. Mito@euMVs-Vt markedly improved mitochondrial architecture and bioenergetic function, thereby alleviating lipid droplet accumulation, cellular senescence, and inflammatory activation that collectively drive atherosclerotic pathology. In an atherosclerotic mouse model, Mito@euMVs-Vt significantly reduced aortic plaque burden, improved vascular compliance, and enhanced fibrous-cap collagen deposition without eliciting systemic toxicity. By integrating selective targeting of inflamed endothelium with functional mitochondrial transfer, this work highlights a promising and mechanistically grounded therapeutic strategy for atherosclerosis.
Language: English
Open Access status: gold
Estimated APC paid: $2,200
OpenAlex ID: W7236446239
FWCI:
Cites: 44
Cited by:
Related to: 10